Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Rudi Beyaert
Profile
Projects
Publications
Activities
Awards & Distinctions
Results
:
ALL
(
70
)
Order By :
Title (a-z)
Title (a-z)
Chronological by starting year (new to old)
As
Promotor-spokesperson
01 January 2024 → 31 December 2027
Dysfunction of enteroendocrine cells in constipation
Funding: Research Foundation - Flanders (FWO)
01 January 2022 → 31 December 2025
Taking IBD Genes from GWAS to Function to Drug Target
Funding: Research Foundation - Flanders (FWO)
As
Promotor
01 January 2012 → 31 December 2017
Amplification of the expression of negative feedback control proteins as a novel anti-inflammatory mechanism of glucocorticoids
Funding: Research Foundation - Flanders (FWO)
01 January 2021 → 31 December 2024
A novel player in intestinal inflammation and motility
Funding: Research Foundation - Flanders (FWO)
01 October 2021 → 30 September 2025
A novel role for CARD14 in prostate cancer
Fellow: Inna Afonina
Funding: Funding by bilateral agreement (private and foundations)
01 January 2014 → 31 December 2014
BCCM "Biological Resource Centre (BRC) - LMBP - C4 / 02/029 - Budget 2014
Funding: Federal funding: various
01 January 2018 → 30 June 2022
BCCM/GeneCorner- budget year 2018-2021
Funding: Federal funding: various
01 January 2015 → 31 December 2015
BCCM/LMBP budget year 2015
Funding: Federal funding: various
01 January 2016 → 31 December 2016
BCCM / LMBP - Budget Year 2016
Funding: Federal funding: various
01 January 2011 → 31 December 2011
Biological Resource Centre (BRC) BCCM/LMBP
Funding: Federal funding: various
01 January 2019 → 31 December 2022
Biosynthesis and physiological role of endogenous mammalian “phytohormones” in health and disease
Funding: Research Foundation - Flanders (FWO)
01 January 2017 → 31 March 2021
CARD14/MALT1 signaling in keratinocytes: from molecular characterisation to validation as therapeutic target
Fellow: Styliani Iliaki
Funding: Research Foundation - Flanders (FWO)
01 January 2007 → 31 December 2009
Characterisation of Pellino proteins as modulators in IL-1 and TLR signal transduction
Funding: Research Foundation - Flanders (FWO)
01 October 2010 → 05 January 2016
Characterisation of ST2/IL-33 signaling and evaluation of the therapeutic potential of nanobody mediated targeting of IL-33
Funding: Regional and community funding: IWT/VLAIO
01 January 2015 → 31 December 2017
Characterisation of the biochemical and physiological function of CARMA2 in the context of psoriasis
Funding: Research Foundation - Flanders (FWO)
01 October 2013 → 31 January 2020
Characterisation of the biochemical and physiological function of CARMA2 in the context of psoriasis
Fellow: Inna Afonina
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 January 2018 → 31 December 2018
Characterisation of the physiological function of CARD14 in the context of psoriasis
Fellow: Inna Afonina
Funding: Research Foundation - Flanders (FWO)
01 January 2008 → 30 December 2012
Characterisation of the physiological role of the NF-kB inhibitor A20 via genetic modification in mice
Funding: Research Foundation - Flanders (FWO)
01 January 2017 → 31 December 2020
Characterization of CARD14 as a novel player in inflammatory bowel disease
Funding: Research Foundation - Flanders (FWO)
01 October 2009 → 26 February 2015
Characterization of group I metabotropic glutamate receptor-induced NF-kappaB signaling in T cells
Fellow: Lynn Elton
Funding: Regional and community funding: IWT/VLAIO
01 January 2015 → 31 December 2017
Characterization of pro-inflammatory signaling in keratinocytes
Funding: Research Foundation - Flanders (FWO)
01 January 2011 → 31 December 2013
Characterization of the in vivo role of MALT1 protease activity in inflammation and immunity
Funding: Research Foundation - Flanders (FWO)
01 October 2008 → 31 March 2011
Characterization of the in vivo role of MALT1 proteolytic activity in inflammation and immunity
Fellow: David Muyllaert
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 October 2007 → 30 September 2011
Characterization of the physiological role of NF-kB inhibitor A20 by genetic modifications into the mouse
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 January 2010 → 31 December 2012
Characterization of the physiological role of the NF-kB and IFN regulatory proteins A20 and DUBA by genetic modification in the mouse.
Funding: Research Foundation - Flanders (FWO)
01 January 2012 → 31 December 2014
Characterization of the role of MALT1 paracaspase in antiviral immunity
Funding: Research Foundation - Flanders (FWO)
01 October 2007 → 30 September 2009
Chlorea toxin as a delivery system for peptide CTL epitopes
Fellow: Kimberly Vanthuyne
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 January 2013 → 31 December 2018
Crosstalk between the MALT1 and Caspase-8 Signaling Complexes in Immune Activation: N-Terminomics versus ubiquitinomics
Funding: Research Foundation - Flanders (FWO)
01 January 2019 → 31 December 2023
Elucidating the details of the interaction between specific nutrients-microbiota-intestinal health and the consequences for inflammatory diseases
Funding: Regional and community funding: Special Research Fund
01 November 2020 → 31 October 2024
Engineering of an abscisic acid (ABA)-producing probiotic yeast strain to modulate host microbiota, intestinal health and inflammatory diseases
Fellow: Femke Van Gaever
Funding: Research Foundation - Flanders (FWO)
01 February 2009 → 30 September 2012
European Consortium of Microbial Resources Centres - EMbaRC
Funding: European funding: framework programme
01 October 2019 → 30 September 2022
From bed to bench: Insights from novel pathogenic RC3H1 and ZC3H12A variants in patients with autoimmune disease and immune dysregulation syndromes.
Fellow: Simon Tavernier
Funding: Research Foundation - Flanders (FWO)
01 January 2014 → 31 December 2019
Functional characterization of MALT1 and CARD14 in psoriasis
Funding: Research Foundation - Flanders (FWO)
01 January 2022 → 31 December 2025
GeneCorner- BCCM "Biological Resource Centre (BRC) - budget 2022-2024
Funding: Federal funding: various
01 October 2022 → 30 September 2025
Harnessing transcriptome and proteome wide analyses and engineered reporter assays to unravel the immunopathogenesis of 'multisystem inflammatory syndrome in children' (MIS-C).
Fellow: Simon Tavernier
Funding: Research Foundation - Flanders (FWO)
01 October 2011 → 30 September 2013
Healthcare applications of targeted protein aggregation
Funding: Regional and community funding: various
01 April 2009 → 30 April 2010
Moleculair and functional characterization of MALT1-proteolytic activity in NF-B activation and lymphoma development
Funding: Funding by bilateral agreement (private and foundations)
01 January 2024 → 31 December 2025
Molecular and cellular mechanisms in inflammation and immunity
Funding: Regional and community funding: Special Research Fund
01 January 2009 → 31 December 2012
Molecular and functional characterization of MALT1-proteolytic activity in NF-kB activation and lymphoma development
Funding: Funding by bilateral agreement (private and foundations)
01 January 2013 → 31 December 2016
Molecular and functional characterization of the tumor suppressors CYLD and A20 as ubiquitin modulating enzymes
Funding: Funding by bilateral agreement (private and foundations)
01 January 2010 → 31 December 2015
Molecular mechanisms involved in the regulation of the paracaspase MALT1 in T cel receptor induced signal transduction
Funding: Research Foundation - Flanders (FWO)
01 October 2014 → 30 September 2018
Molecular mechanisms regulating the activity and specificity of CYLD in T cells
Fellow: Marie Lork
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 January 2010 → 31 December 2015
Negative regulation of NF-kB in the pathophysiology of rheumatoid arthritis and systemic lupus erythermatosus
Funding: Research Foundation - Flanders (FWO)
01 January 2013 → 31 October 2018
Novel anti-inflammatory mechanisms of glucocorticoids – towards a higher safety and efficacy
Funding: Regional and community funding: Special Research Fund
01 January 2009 → 31 December 2012
Novel macrophage and myeloid dendritic cell markers for in vivo imaging and therapy of inflammatory diseases; Inflammation tracking "Inflammatrack"
Funding: Regional and community funding: various
01 October 2007 → 01 October 2009
Respiratory Syncitial Virus immunology and molecular virology
Funding: Regional and community funding: Special Research Fund
22 July 2010 → 31 December 2015
RNAI collection and associated facilities
Funding: Research Foundation - Flanders (FWO)
01 January 2013 → 31 December 2018
Role and regulation of the anti-inflammatory protein A20 in selective autophagy
Funding: Research Foundation - Flanders (FWO)
01 November 2023 → 31 October 2027
Role of linear ubiquitination in intestinal inflammation and disease
Fellow: Femke De Meyer
Funding: Research Foundation - Flanders (FWO)
01 October 2012 → 30 September 2016
Role of MALT1 in neuronal cells.
Fellow: Alice Borghi
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 January 2017 → 31 December 2020
Role of MALT1 proteolytic activity in prostate cancer.
Funding: Funding by bilateral agreement (private and foundations)
01 January 2012 → 31 December 2015
STRETCH: mechanotransduction in osteoimmunology: an innovative approach towards effective drug for rheumatic diseases
Funding: Regional and community funding: various
01 October 2008 → 30 September 2014
Structure-function analysis of the human paracaspase MALT1 in antigen receptor induced signal transduction to NF-kB dependent gene expression
Fellow: Jens Staal
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 October 2014 → 30 September 2018
Study of phagosomes of inflammatory dendritic cells as an intracellular platform to shape immune responses
Fellow: Anne-Marie Pauwels
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 October 2009 → 13 January 2017
Study of the molecular mechanisms regulating the activity and expression of the de-ubiquitinase protein DUBA in innate immune signaling.
Fellow: Lynn Verstrepen
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 November 2008 → 01 October 2009
Study of the molecular mechanisms that regulate the activity and the expression of the protein-ubiquitinerend DUBA in innate immune signaling.
Funding: Regional and community funding: Special Research Fund
01 January 2008 → 31 December 2014
Study of the role of NF-kB regulatory signalling molecules involved in multiple sclerosis through gene targeting in the mouse
Funding: Funding by bilateral agreement (private and foundations)
01 October 2014 → 30 September 2018
The impact of MALT1 and MALT1-mediated CYLD cleavage on the development of IBD
Fellow: Elien Van Nuffel
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 October 2008 → 30 September 2012
The in vivo study of signaling pathways involved in cell survival and cell death within the central nervous system
Fellow: Conor Mc Guire
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 January 2019 → 31 December 2021
The role of the C3H1 zinc finger protein Roquin1 in inflammation, from a genetic survey in hyperinflammatory disorders to therapeutic applicability.
Fellow: Simon Tavernier
Funding: Regional and community funding: Special Research Fund
01 January 2010 → 31 December 2010
Toll-like receptor 3 (TLR3) stimulation in the treatment of cancer
Funding: Funding by bilateral agreement (private and foundations)
15 October 2016 → 30 June 2019
Valorisation of cytokine traps: IL33 as lead case
Funding: Regional and community funding: Industrial Research Fund
As
Copromotor
01 May 2024 → 30 April 2028
FullPicture: Combining Spectral Flow Cytometry with High-Speed Cell Imaging to enable comprehensive profiling of plant and animal cells and their components in real time.
Funding: Research Foundation - Flanders (FWO)
01 February 2013 → 31 January 2015
POXylation as next generation PEGylation
Funding: Regional and community funding: various
01 June 2018 → 31 May 2020
Purchase steam autoclave central kitchen Department of Biomedical Molecular Biology
Funding: Regional and community funding: Special Research Fund
01 January 2012 → 31 December 2017
Study of the impact of CYLD cleavage on lymphocyte function in vivo and its potential contribution to inflammatory and autoimmune disorders
Funding: Research Foundation - Flanders (FWO)
01 July 2007 → 30 June 2014
Study of the (patho)physiological role of NF-kB inhibitors A20 and ABINs through genetic
Funding: Research Foundation - Flanders (FWO)
01 January 2011 → 31 December 2014
Study of the role of the NF-kB-inhibitory protein A20 in inflammation-associated cancer
Funding: Research Foundation - Flanders (FWO)
01 October 2012 → 30 September 2015
T cell receptor signaling pathways in autoimmune disease: the in vivo role of CYLD cleavage
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 May 2020 → 30 April 2024
The BD FACS Symphony FACS cell sorter: the most advanced multiparameter fluorescence activated cell sorter that allows the identification and purification of rare cells for further functional characterization
Funding: Research Foundation - Flanders (FWO)